CD8A and familial pancreatic carcinoma: In mice with pancreatic tumours, the hydrogel vaccine combined with ablation therapy effectively promotes systematic amplification of cDC1/CD8+ T-cell antitumor immunity, inhibiting pancreatic cancer progression.